Patel Sanj K

USNatural personCEO

Transactions

331

Issuers

Buys / Sells

1/85

Last tx

30 Apr 2026

FrançaisSign in Try free 14d

Insider

Patel Sanj K

USNatural personCEO

Transactions

331

Issuers

Buys / Sells

1/85

Last tx

30 Apr 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
BIOCRYST PHARMACEUTICALS INC	30,000	reported	24 May 2017	tx 3+76,667
Syros Pharmaceuticals, Inc.	11,000	reported	08 Jun 2017	tx 3+44,000
INTERCEPT PHARMACEUTICALS INC	551	reported	17 Jul 2014	tx 2+1,003
TRIMERIS INC	0	reported	22 Jun 2015	tx 138+1,397,800−2,319,981
Kiniksa Pharmaceuticals International, plc	0	reported	30 Apr 2026	tx 187+6,994,440−5,526,210

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	431,904	10.36 USD	10b5-1
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	51,750	30.93 USD	10b5-1
28 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	74,635	50.43 USD	10b5-1
28 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	113,673	51.47 USD	10b5-1
28 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	243,596	52.02 USD	10b5-1
28 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	51,750	54.02 USD	10b5-1
29 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	22,544	30.93 USD	10b5-1
29 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	22,544	54.01 USD	10b5-1
30 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	2,141	30.93 USD	10b5-1
30 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	2,141	54.01 USD	10b5-1
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	431,904	0.00 USD	10b5-1deriv
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	51,750	0.00 USD	10b5-1deriv
29 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	22,544	0.00 USD	10b5-1deriv
30 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	2,141	0.00 USD	10b5-1deriv
12 Nov 2025	GIFT	Kiniksa Pharmaceuticals International, plc	111,794	0.00 USD
12 Nov 2025	GIFT	Kiniksa Pharmaceuticals International, plc	111,794	0.00 USD
13 Nov 2025	GIFT	Kiniksa Pharmaceuticals International, plc	60,000	0.00 USD
13 Nov 2025	GIFT	Kiniksa Pharmaceuticals International, plc	60,000	0.00 USD
20 Oct 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	121,248	3.80 USD
20 Oct 2025	SALE	Kiniksa Pharmaceuticals International, plc	98,934	38.81 USD
20 Oct 2025	SALE	Kiniksa Pharmaceuticals International, plc	22,314	39.32 USD
21 Oct 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	39,331	3.80 USD
21 Oct 2025	SALE	Kiniksa Pharmaceuticals International, plc	39,331	38.77 USD
22 Oct 2025	SALE	Kiniksa Pharmaceuticals International, plc	97,390	38.83 USD
22 Oct 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	97,390	3.80 USD

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
BIOCRYST PHARMACEUTICALS INC	30,000	reported	24 May 2017	tx 3+76,667
Syros Pharmaceuticals, Inc.	11,000	reported	08 Jun 2017	tx 3+44,000
INTERCEPT PHARMACEUTICALS INC	551	reported	17 Jul 2014	tx 2+1,003
TRIMERIS INC	0	reported	22 Jun 2015	tx 138+1,397,800−2,319,981
Kiniksa Pharmaceuticals International, plc	0	reported	30 Apr 2026	tx 187+6,994,440−5,526,210

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	431,904	10.36 USD	10b5-1
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	51,750	30.93 USD	10b5-1
28 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	74,635	50.43 USD	10b5-1
28 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	113,673	51.47 USD	10b5-1
28 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	243,596	52.02 USD	10b5-1
28 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	51,750	54.02 USD	10b5-1
29 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	22,544	30.93 USD	10b5-1
29 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	22,544	54.01 USD	10b5-1
30 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	2,141	30.93 USD	10b5-1
30 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	2,141	54.01 USD	10b5-1
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	431,904	0.00 USD	10b5-1deriv
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	51,750	0.00 USD	10b5-1deriv
29 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	22,544	0.00 USD	10b5-1deriv
30 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	2,141	0.00 USD	10b5-1deriv
12 Nov 2025	GIFT	Kiniksa Pharmaceuticals International, plc	111,794	0.00 USD
12 Nov 2025	GIFT	Kiniksa Pharmaceuticals International, plc	111,794	0.00 USD
13 Nov 2025	GIFT	Kiniksa Pharmaceuticals International, plc	60,000	0.00 USD
13 Nov 2025	GIFT	Kiniksa Pharmaceuticals International, plc	60,000	0.00 USD
20 Oct 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	121,248	3.80 USD
20 Oct 2025	SALE	Kiniksa Pharmaceuticals International, plc	98,934	38.81 USD
20 Oct 2025	SALE	Kiniksa Pharmaceuticals International, plc	22,314	39.32 USD
21 Oct 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	39,331	3.80 USD
21 Oct 2025	SALE	Kiniksa Pharmaceuticals International, plc	39,331	38.77 USD
22 Oct 2025	SALE	Kiniksa Pharmaceuticals International, plc	97,390	38.83 USD
22 Oct 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	97,390	3.80 USD